4/29
06:09 am
bmy
Repertoire® Immune Medicines and Bristol Myers Squibb Announce Multi-Year Strategic Collaboration to Develop Tolerizing Vaccines for Autoimmune Diseases [Yahoo! Finance]
Low
Report
Repertoire® Immune Medicines and Bristol Myers Squibb Announce Multi-Year Strategic Collaboration to Develop Tolerizing Vaccines for Autoimmune Diseases [Yahoo! Finance]
4/29
06:00 am
bmy
Repertoire® Immune Medicines and Bristol Myers Squibb Announce Multi-Year Strategic Collaboration to Develop Tolerizing Vaccines for Autoimmune Diseases
Low
Report
Repertoire® Immune Medicines and Bristol Myers Squibb Announce Multi-Year Strategic Collaboration to Develop Tolerizing Vaccines for Autoimmune Diseases
4/27
10:05 am
bmy
Bristol-Myers Squibb First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags [Yahoo! Finance]
Low
Report
Bristol-Myers Squibb First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags [Yahoo! Finance]
4/26
02:36 pm
bmy
Bristol-Myers Squibb (NYSE: BMY) had its price target lowered by analysts at BMO Capital Markets from $55.00 to $48.00. They now have a "market perform" rating on the stock.
Low
Report
Bristol-Myers Squibb (NYSE: BMY) had its price target lowered by analysts at BMO Capital Markets from $55.00 to $48.00. They now have a "market perform" rating on the stock.
4/26
11:14 am
bmy
Bristol-Myers Squibb (NYSE: BMY) had its price target lowered by analysts at Barclays PLC from $51.00 to $43.00. They now have an "equal weight" rating on the stock.
Low
Report
Bristol-Myers Squibb (NYSE: BMY) had its price target lowered by analysts at Barclays PLC from $51.00 to $43.00. They now have an "equal weight" rating on the stock.
4/26
07:08 am
bmy
CHMP Adopts Positive Opinion Recommending Approval of Bristol Myers Squibb's Opdivo® (nivolumab) in Combination with Cisplatin and Gemcitabine for the First-Line Treatment of Adult Patients with Unresectable or Metastatic Urothelial Carcinoma [Yahoo! Fin
Low
Report
CHMP Adopts Positive Opinion Recommending Approval of Bristol Myers Squibb's Opdivo® (nivolumab) in Combination with Cisplatin and Gemcitabine for the First-Line Treatment of Adult Patients with Unresectable or Metastatic Urothelial Carcinoma [Yahoo! Fin
4/26
06:59 am
bmy
CHMP Adopts Positive Opinion Recommending Approval of Bristol Myers Squibb’s Opdivo® (nivolumab) in Combination with Cisplatin and Gemcitabine for the First-Line Treatment of Adult Patients with Unresectable or Metastatic Urothelial Carcinoma
Low
Report
CHMP Adopts Positive Opinion Recommending Approval of Bristol Myers Squibb’s Opdivo® (nivolumab) in Combination with Cisplatin and Gemcitabine for the First-Line Treatment of Adult Patients with Unresectable or Metastatic Urothelial Carcinoma
4/25
04:24 pm
bmy
Bristol-Myers Squibb Stock: Gloomy Q1 Earnings Trigger Justified Sell-Off [Seeking Alpha]
Neutral
Report
Bristol-Myers Squibb Stock: Gloomy Q1 Earnings Trigger Justified Sell-Off [Seeking Alpha]
4/25
02:35 pm
bmy
Bristol Myers Squibb Swings To Quarterly Loss, After String Of Multi-Billion Acquisitions [Yahoo! Finance]
Low
Report
Bristol Myers Squibb Swings To Quarterly Loss, After String Of Multi-Billion Acquisitions [Yahoo! Finance]
4/25
01:40 pm
bmy
Bristol-Myers (BMY) Q1 Loss Narrower Than Expected, Sales Beat [Yahoo! Finance]
Low
Report
Bristol-Myers (BMY) Q1 Loss Narrower Than Expected, Sales Beat [Yahoo! Finance]
4/25
12:03 pm
bmy
Why Bristol Myers Squibb Stock Is Sinking Today [Yahoo! Finance]
Low
Report
Why Bristol Myers Squibb Stock Is Sinking Today [Yahoo! Finance]
4/25
11:44 am
bmy
Bristol Myers (BMY) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates [Yahoo! Finance]
Low
Report
Bristol Myers (BMY) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates [Yahoo! Finance]
4/25
11:44 am
bmy
Bristol Myers Squibb (BMY) Q1 2024 Earnings Call Transcript [Yahoo! Finance]
Low
Report
Bristol Myers Squibb (BMY) Q1 2024 Earnings Call Transcript [Yahoo! Finance]
4/25
10:53 am
bmy
Is Bristol Myers Squibb Stock a Millionaire Maker? [Yahoo! Finance]
Low
Report
Is Bristol Myers Squibb Stock a Millionaire Maker? [Yahoo! Finance]
4/25
08:56 am
bmy
International Myeloma Foundation Holds 15th Annual Gala at the Edison Ballroom in New York City on April 18 [Yahoo! Finance]
Low
Report
International Myeloma Foundation Holds 15th Annual Gala at the Edison Ballroom in New York City on April 18 [Yahoo! Finance]
4/25
07:02 am
bmy
Bristol-Myers Squibb Company Non-GAAP EPS of -$4.40 beats by $0.02, revenue of $11.78B beats by $330M [Seeking Alpha]
Medium
Report
Bristol-Myers Squibb Company Non-GAAP EPS of -$4.40 beats by $0.02, revenue of $11.78B beats by $330M [Seeking Alpha]
4/25
06:59 am
bmy
Bristol Myers Squibb Reports First Quarter Financial Results for 2024
Medium
Report
Bristol Myers Squibb Reports First Quarter Financial Results for 2024
4/24
10:15 am
bmy
Obsidian Therapeutics to Present Clinical Data from OBX-115, its Engineered TIL Cell Therapy, for Patients with Advanced Solid Tumors in Oral Presentation at the 2024 ASCO Annual Meeting [Yahoo! Finance]
Low
Report
Obsidian Therapeutics to Present Clinical Data from OBX-115, its Engineered TIL Cell Therapy, for Patients with Advanced Solid Tumors in Oral Presentation at the 2024 ASCO Annual Meeting [Yahoo! Finance]
4/24
09:12 am
bmy
Overhaul Unites Supply Chain Leaders with New Partner Ecosystem Program to Combat Global Cargo Theft [Yahoo! Finance]
Low
Report
Overhaul Unites Supply Chain Leaders with New Partner Ecosystem Program to Combat Global Cargo Theft [Yahoo! Finance]
4/24
08:07 am
bmy
The Galien Foundation Announces 2024 Prix Galien International Awards Nominees [Yahoo! Finance]
Low
Report
The Galien Foundation Announces 2024 Prix Galien International Awards Nominees [Yahoo! Finance]
4/22
05:13 pm
bmy
Alexandria Real Estate's Q1 FFO rises on stronger occupancy rates [Yahoo! Finance]
Low
Report
Alexandria Real Estate's Q1 FFO rises on stronger occupancy rates [Yahoo! Finance]
4/22
03:58 pm
bmy
Bristol-Myers' (BMY) to Report Q1 Earnings: What You Should Know [Yahoo! Finance]
Neutral
Report
Bristol-Myers' (BMY) to Report Q1 Earnings: What You Should Know [Yahoo! Finance]
4/22
10:56 am
bmy
Curious about Bristol Myers (BMY) Q1 Performance? Explore Wall Street Estimates for Key Metrics [Yahoo! Finance]
Low
Report
Curious about Bristol Myers (BMY) Q1 Performance? Explore Wall Street Estimates for Key Metrics [Yahoo! Finance]
4/22
09:58 am
bmy
Bristol-Myers, Cellares ink $380M CAR-T therapies supply deal [Seeking Alpha]
Low
Report
Bristol-Myers, Cellares ink $380M CAR-T therapies supply deal [Seeking Alpha]
4/22
09:46 am
bmy
Interstitial Lung Disease Pipeline Research 2024: Therapeutic Assessment of 120+ Pipeline Drugs [Yahoo! Finance]
Neutral
Report
Interstitial Lung Disease Pipeline Research 2024: Therapeutic Assessment of 120+ Pipeline Drugs [Yahoo! Finance]